spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  ANA Therapeutics 

 HSMN NewsFeed - 5 Dec 2024
Sapience Therapeutics Strengthens Board of Directors and Management Team with Esteemed Business Development Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2022
Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Aug 2020
ANA Therapeutics Announces U.S. FDA Clearance Of IND Application To Initiate Clinical Trial Of Niclosamide In COVID-19 Patients
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Apr 2019
Aratana Therapeutics to be Acquired by Elanco Animal Health
Biopharmaceuticals Veterinary Mergers & Acquisitions
 HSMN NewsFeed - 4 Feb 2019
Aratana Therapeutics Appoints Rhonda Hellums Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Nov 2017
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 Jan 2016
Cerecor Inc. Appoints Thomas Aasen to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 10 Aug 2015
Aratana Therapeutics Elects Wendy Yarno as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jul 2015
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Mar 2015
Mersana Raises $35 Million in Series B Financing and Appoints Anna Protopapas as President and Chief Executive Officer
Devices Drug Delivery Venture Capital Personnel
 HSMN NewsFeed - 10 Oct 2014
Regado Biosciences Appoints Michael A. Metzger CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2013
Regado Biosciences Strengthens Executive Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2012
Zyngenia, Inc. Expands Its Board of Directors with Leading Life Sciences Business Executives Christian Itin and Jason Rhodes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 May 2012
Polynoma Appoints John Chiplin, Ph.D., Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Jan 2012
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 6 Sep 2011
Oceana Therapeutics Announces U.S. Launch of Solesta(R), The Only Nonsurgical FDA Approved Treatment for Patients Who Fail Conservative Therapy for Fecal (Bowel) Incontinence
Devices
 HSMN NewsFeed - 31 May 2011
FDA Approves Solesta(R); Novel Specialty Therapeutic Addresses Large Treatment Void for Patients with Life-Altering Fecal (Bowel) Incontinence
Devices Gastroenterology FDA
 HSMN NewsFeed - 20 Apr 2011
Mersana Therapeutics Appoints Michael A. Metzger as EVP & COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2011
Oceana Therapeutics Gets FDA Approvable Letter for Solesta(R), a Significant Treatment Option for Fecal (Bowel) Incontinence; the Only Minimally Invasive Therapy for More Severe Bowel Control Problems
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jan 2011
Aratana Therapeutics Announces $20 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Dec 2010
NovaDigm Therapeutics Appoints C. Boyd Clarke to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Dec 2010
Oceana Therapeutics Announces FDA Advisory Committee Recommends Approval of Solesta(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Sep 2010
Mersana Therapeutics Appoints Nicholas Bacopoulos President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2010
Acetylon Pharmaceuticals Tops Up Series A Financing with $2 Million Note And Appoints Simon Jones VP Biology and Preclinical Development and John van Duzer VP Chemistry and Manufacturing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 26 Oct 2009
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Feb 2009
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Sep 2008
Oceana Therapeutics Commences Operations after Completing Series A Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Feb 2008
Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jan 2008
Mersana Therapeutics, Inc. Appoints John H. van Duzer, Ph.D., as Vice President of Manufacturing and Pharmaceutical Sciences
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2007
Alnylam Expands Management Team with New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jul 2007
Mersana Therapeutics, Inc. Appoints Pharmaceutical Industry Veteran Nicholas G. Bacopoulos, Ph.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2007
Semafore Pharmaceuticals Appoints Dr. Ullrich Schwertschlag Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 May 2007
Mersana Therapeutics, Inc. Announces the Appointment of Robert J. Fram, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 9 additional stories matching:
ANA Therapeutics
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!